Indexed in MEDLINE, SCI & KoreaMed
pISSN 1011-8934   eISSN 1598-6357
Open Access, Peer-reviewed, Weekly
    J Korean Med Sci. 2019 Jan 14;34(2):e11. English.
    Published online Jan 02, 2019.
    https://doi.org/10.3346/jkms.2019.34.e11
    © 2019 The Korean Academy of Medical Sciences.
    Original Article

    Clinical Characteristics of Oral Allergy Syndrome in Children with Atopic Dermatitis and Birch Sensitization: a Single Center Study

    Kang-in Kim,1 Bomi Lee,1 Taek Ki Min,1 Jeongho Lee,2 Bok Yang Pyun,1 and You Hoon Jeon3
      • 1Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea.
      • 2Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea.
      • 3Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
    • Address for Correspondence: Bok Yang Pyun, MD, PhD. Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, 59 Daesagwan-gil, Yongsan-gu, Seoul 04401, Korea. Email: bypyun@schmc.ac.kr
      Address for Correspondence: You Hoon Jeon, MD, PhD. Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong 18450, Republic of Korea. Email: jeonyouhoon@hanmail.net
    Received August 06, 2018; Accepted October 17, 2018.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Abstract

    Background

    Oral allergy syndrome (OAS) is an immunoglobulin E (IgE)-mediated hypersensitivity that occurs frequently in older children with pollen sensitization. This study focused on the clinical characteristics of OAS in children with atopic dermatitis (AD) and birch sensitization.

    Method

    s: A total of 186 patients aged 2–18 years with AD and birch sensitization were enrolled in this study between January 2016 and March 2017. Their levels of serum total IgE and birch- and ragweed-specific IgE (sIgE) were measured using ImmunoCAP (Thermo Fisher Scientific, Uppsala, Sweden). Information regarding causative foods and symptoms were obtained via interviews. The patients were divided into 3 groups according to their ages (group 1, 2–6 years; group 2, 7–12 years; and group 3, 13–18 years).

    Results

    Eighty-one of the 186 (43.5%) children with AD who were sensitized to birch pollen were diagnosed as having OAS. The prevalence of OAS in group 1 (the children who had AD and birch sensitization aged 2–6 years) was 36.6%. A greater predominance of men was noted in the non-OAS group (77.1%) compared to the OAS group (60.5%). Apples were the most common causative food in group 2 and 3 while kiwis were the most common cause of OAS in group 1. There was a statistically significant correlation between birch-sIgE levels and the prevalence of OAS (P = 0.000). The cut-off value was 6.77 kUA/L with 55.6% sensitivity and 79.0% specificity (area under the curve 0.653).

    Conclusion

    In our study, the prevalence of OAS in children with AD and birch sensitization was 43.5%. Even in the preschool age group, the prevalence of OAS was considerable. Patients with high levels of birch-sIgE were more likely to have OAS. Clinicians should therefore be vigilant about OAS in patients with a high degree of sensitization to birch pollen and even young children if they have birch sensitization.

    Graphical Abstract

    Keywords
    Oral Allergy Syndrome; Children; Atopic Dermatitis; Birch

    INTRODUCTION

    Oral allergy syndrome (OAS) is an immunoglobulin E (IgE)-mediated hypersensitivity that occurs frequently in older children with pollen sensitization. OAS results from the cross-reactivity between pollen sensitization and food proteins due to their homologous protein structures. OAS is therefore also known as pollen-food syndrome. Patients who are sensitized to pollen frequently present with allergic symptoms after the ingestion of certain fruits, vegetables, and nuts.

    The symptom complex consists of itching, a tingling or burning sensation, and swelling of the lips, mouth, and throat immediately after the ingestion of plant-derived foods. The symptoms may sometimes develop into urticaria, conjunctivitis, nausea, vomiting, asthma, and anaphylaxis.1, 2

    The number of epidemiological studies investigating OAS in pediatric populations is limited. A few international studies have reported that the prevalence of OAS is 5.0%–29.7% in children and 4.1%–70.0% in adults.3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 A nationwide multicenter study conducted in Korea in 2017 reported that the prevalence of OAS in Korean pollinosis patients was 41.7%.14

    Birch pollen-related food allergy is considered a common immunologic cross-reactivity between ubiquitous birch pollen and structurally related food proteins. Food proteins also interact with each other.15, 16, 17 There are only a few studies regarding OAS in atopic dermatitis (AD) children, and birch sensitization exacerbates their skin and perioral symptoms when they eat certain foods. The OAS symptoms are reported more often by patients with a birch pollen allergy (70%) than by patients without a birch pollen allergy (19%).18, 19, 20 We therefore focused our study on OAS in children with birch pollen sensitization.

    The aim of this study was to determine the characteristics of OAS in the Korean pediatric population with birch pollen sensitization and AD.

    METHODS

    Patients

    Outpatients attending the Department of Pediatrics at Soonchunhyang University Hospital between January 2016 and March 2017 were recruited for this study. A total of 186 patients aged 2–18 years who had AD and birch sensitization were enrolled in this study. We performed a retrospective medical record review of the enrolled patients. The patients were divided into 3 groups according to their ages (group 1, 2–6 years; group 2, 7–12 years; and group 3, 13–18 years).

    Serum specific IgE (sIgE) measurements

    Blood samples were taken to detect the patients' total IgE (tIgE) and birch-sIgE levels using the ImmunoCAP test (Thermo Fisher Scientific, Uppsala, Sweden) at their first or follow-up visits. Levels were expressed in kUA/L within 7 classes, the upper limits of which were: class 0, 0.35 kUA/L; class 1, 0.7 kUA/L; class 2, 3.5 kUA/L; class 3, 17.5 kUA/L; class 4, 50 kUA/L; class 5, 100 kUA/L; class 6, > 100 kUA/L. The classes ≥ 1 were considered positive.

    Pediatric population interviews

    Interviews regarding their OAS symptoms (e.g., itching, burning, swelling, and rash) were carried out with the children with AD and birch sensitization. Information about the kinds and number of causative foods was also obtained. If children could not explain their symptoms and causative foods, we obtained the information from their parents.

    Statistics

    A two-tailed unpaired t-test or otherwise a nonparametric Mann-Whitney U test was applied to compare the results between the groups. The χ2 test or Fisher's exact test was used to compare the frequencies between the groups. A P value < 0.05 was considered statistically significant. The cut-off level of sIgE against birch to predict OAS was determined by analyzing the receiver operating characteristic (ROC) curves. SPSS version 22.0 (SPSS Inc., Chicago, IL, USA) was used for all the analyses.

    Ethics statement

    The present study protocol was reviewed and approved by the Institutional Review Board (IRB) of Soonchunhyang University Hospital (IRB No. 2018-07-024). The need for informed consent was waived by the board.

    RESULTS

    Demographics and prevalence

    A total of 186 patients with AD and birch sensitization (130 male and 56 female patients) were included in this study. Of these, 81 (43.5%) had OAS at the time of their visit to the hospital. The number of male patients with OAS was 49 while the number of female patients with OAS was 32. Eighty-six patients (46.2%) had ragweed co-sensitization. The data on sex, age, tIgE, birch-sIgE, ragweed-sIgE, and comorbidities of allergic rhinitis and asthma were summarized according to the existence of OAS (Table 1).

    Table 1
    The characteristics of OAS and the absence of OAS in pediatric patients with birch sensitization and AD

    There was a difference in the male:female sex ratio between the patients with OAS and those without OAS (P = 0.014). A comparison of the male:female sex ratios of the patients revealed a much smaller difference (1.53:1) for those with OAS compared to those without OAS (3.38:1) (sex ratio for the total population, 2.32:1).

    Most of the study population (90.9%, 169/186) had allergic rhinitis, and 17% (32/186) had asthma. However, no relevant difference was found in their comorbidities according to the existence of OAS. There was also no statistical difference in age between with those with OAS (median, 7.0; interquartile range [IQR], 4.50–9.00) and those without OAS (median, 6.0; IQR, 3.00–9.00).

    Correlation between pollen sIgE and OAS

    We analyzed the serum levels of tIgE (n = 186), birch-sIgE (n = 186), and ragweed-sIgE (n = 149). No difference in tIgE levels between the patients with OAS and those without OAS was found (median, 369.0 kUA/L; IQR, 175.0–1,038.0 and median, 418.0 kUA/L; IQR, 200.5–1,109.0, respectively). There was also no statistical difference in the levels of ragweed-sIgE between the patients with OAS and those without OAS (median, 0.550; IQR, 0.160–2.590 and median, 0.400; IQR, 0.150–1.948, respectively). Additionally, the OAS prevalence of the group with ragweed sensitization and without ragweed sensitization showed no statistical difference (44.2% vs. 39.7%, respectively).

    However, the birch-sIgE levels were significantly higher in the group with OAS (median, 7.580; IQR, 1.175–23.750) than in the group without OAS (median, 1.42; IQR, 0.620–5.770). When comparing the presence of OAS by birch-sIgE class, it was found that the proportion of patients with OAS increased to birch-sIgE class 3 and above although there were more patients without OAS below class 3 (Table 1).

    The ROC curve analysis indicated a birch-sIgE of 6.77 kUA/L, which was set as the optimal cut-off point for assessing the diagnostic value of OAS. The area under the curve (AUC) was 0.653, with a sensitivity of 55.6% and a specificity of 79.0% for the cut-off value of ≥ 6.77 required for an OAS diagnosis (Fig. 1).

    Fig. 1
    Optimal cut-off values of birch-sIgE established via ROC analysis.
    sIgE = specific immunoglobulin E, ROC = receiver operating characteristic, AUC = area under the curve, CI = confidence interval, PPV = positive predictive value, NPV = negative predictive value.

    Causative foods and symptoms

    There were significant differences in the number of causative foods in each age group (P = 0.001). The older age groups described more causative foods than the younger groups (Table 2). The most frequent causative foods were apples (n = 33), followed in order by kiwis (n = 26), peaches (n = 21), and pineapples (n = 18). Kiwis were the most common causative food in group 1 (n = 11) while apples were in group 2 (n = 19) and group 3 (n = 5) (Table 3).

    Table 2
    The relationship between age groups in the pediatric population and the number of causative foods in OAS

    Table 3
    The causative foods of OAS among pediatric patients with AD and birch sensitization by age group

    Itching was the most common symptom in this study, followed by rash across all the age groups. In the youngest age group (group 1), rash was the most common symptom (Table 4).

    Table 4
    The symptoms of OAS in pediatric patients with AD and birch sensitization by age group

    DISCUSSION

    In 1987, Amlot et al.18 first reported “oral allergy syndrome,” which comprises symptoms induced by eating a particular food. It includes primarily oral mucosal symptoms and, occasionally, systemic symptoms. The term “pollen-food allergy syndrome” is also used, but OAS is the more specific term. In 2003 and 2005, Ma et al.3 and Kondo and Urisu,19 respectively, reviewed OAS that is restricted to the oral mucosa.

    The prevalence of OAS in children has rarely been investigated. In the United States in 2003,3 a survey among allergists reported that the prevalence of OAS was 5% in children with atopic diseases. Meanwhile, a study involving children with pollen-induced allergic rhinitis in Italy found that the prevalence was 24%.6 By way of contrast, a 2014 study in Australia7 assessing 163 patients aged 4–17 years found that the occurrence of OAS was 14.7%, while in Mexico in 2016,10 267 Mexican children with atopic disease, aged 6–14 years, were evaluated and the OAS prevalence was determined to be 8.9%. In this study, the prevalence of OAS was 45.7%, which is higher than that in other studies. This is because the study population was limited to birch sensitization children with AD.

    There is no study on higher prevalence of OAS in the children with AD and birch sensitization. According to Eigenmann et al,21 the prevalence of food allergy in children with AD is significantly higher than the general population. Severity of AD is a major risk factor for food allergy22 and birch pollen-related food is a provocation factor of allergic symptoms in AD patients.23 In addition, it is already known that OAS and AD both belong to IgE mediated hypersensitivity.18, 24, 25 For this reason, we presumed OAS and AD may be interrelated with each other, like the relationship between food allergy and AD. Further studies about the correlation analysis and case-control study between OAS with AD are necessary. Because the prevalence of OAS in group 1 (the children who had AD and birch sensitization aged 2–6 years) was 36.6% in this study, clinicians should be aware that OAS can occur in young children.

    There was a difference in the sex ratio between the OAS group and the non-OAS group in this study. The percentage of male patients without OAS was 77.1% but 60.5% in those with OAS. This result is very similar to that of the Italian study, which reported that the percentage of male patients without OAS was 70% and, in those with OAS, 61%.6 Another study found that male patients without OAS accounted for 37.5% of the study population, which contrasted with the 28.1% of male patients with OAS.9 Further studies on OAS in relation to sex are thus required.

    The Italian report6 stated that patients with allergic rhinitis had severe symptoms if they had asthma or OAS. Furthermore, patients with allergic rhinitis and AD have shown a higher prevalence of OAS.9 Notwithstanding, in this study there were no significant differences in the prevalence of comorbidities such as allergic rhinitis and asthma between the groups with OAS and those without OAS.

    There are no standard diagnostic criteria for OAS. The diagnosis of OAS depends on the patient's clinical history and conformational tests such as the ImmunoCAP test (sIgE), skin prick test, and food challenge test.2, 11, 26 We found a significant difference in birch-sIgE levels between the group with OAS (7.580) and the group without OAS (1.420). Moreover, when the class of birch-sIgE changed from 1 to 6, the prevalence increased concomitantly from 31.9% to 85.7%. Where birch-sIgE levels were class 3 or higher, there were more patients with OAS than those without OAS. This result means that levels of birch-sIgE can help diagnose OAS. We calculated the diagnostic value of birch-sIgE using the ROC curve. The cut-off value was 6.77 kUA/L with 55.6% sensitivity and 79.0% specificity (AUC 0.653).

    No significant differences were identified in the prevalence of OAS according to the existence of ragweed sensitization (44.4% in the ragweed positive group and 41.9% in the ragweed negative group). The prevalence of OAS in terms of ragweed-sIgE levels showed no statistical differences, either. It seems that the influence of ragweed sensitization on OAS was low compared to that of birch sensitization. Some studies have shown that geographic and dietary differences account for various influences in OAS prevalence.6, 12, 13, 17 An investigation should be done to determine the relationship between OAS and each kind of pollen sensitization in Korea. Nevertheless, further studies to improve diagnostic tests will also be necessary so that a more specific approach to the diagnosis of OAS in Korea can be developed.

    The causative foods and symptoms differed depending on the age group. We found that the older age groups had a large number of causative foods than the younger groups. In this study, itching was the most common symptom, followed by rash. However, for group 1 (younger children aged 2–6 years), rash was the most common symptom. This may be because itching is not well expressed by young children whereas rash can be recognized quickly by parents. The most frequent causative foods were apples, followed in order by kiwis, peaches, and pineapples. This result mirrors those of other studies regarding the most common foods causing birch sensitization in OAS.3, 12, 13, 15, 20, 27

    This study had some limitations. First, the prevalence of OAS was calculated for a specific population of children with both AD and birch sensitization. Because of that, the actual prevalence in the pediatric population could have been overestimated. Second, this study was performed in a single center. A nationwide study of the entire pediatric population is thus needed. Lastly, we could not conduct food challenge tests, and the information regarding causative foods was obtained through interviews with patients only.

    The aim of this study was to determine the characteristics of OAS in the Korean pediatric population. There are many studies about OAS in children overseas; however, this is the first attempt to evaluate OAS in Korean children with AD and birch sensitization. Accordingly, our results have important implications for future studies about OAS in our country.

    In conclusion, the prevalence of OAS in the children with AD and birch sensitization in this study was high at 43.5%. Even in the preschool age group, the prevalence of OAS was considerable. Furthermore, we found that patients with high levels of birch-sIgE were more likely to have OAS. Clinicians should therefore be vigilant about OAS in patients with a high degree of sensitization to birch pollen and even young children if they have birch sensitization.

    Notes

    Funding:This work was supported in part by the Soonchunhyang University Research Fund.

    Disclosure:The authors have no potential conflicts of interest to disclose.

    Author Contributions:

    • Conceptualization: Kim KI, Min TK, Lee J, Pyun BY, Jeon YH.

    • Data curation: Kim KI, Lee B, Min TK, Jeon YH.

    • Formal analysis: Kim KI, Jeon YH.

    • Investigation: Kim KI, Lee B.

    • Methodology: Kim KI, Pyun BY, Jeon YH.

    • Validation: Kim KI, Min TK, Pyun BY, Jeon YH.

    • Writing - original draft: Kim KI.

    • Writing - review & editing: Kim KI, Min TK, Lee J, Pyun BY, Jeon YH.

    References

      1. Ortolani C, Ispano M, Pastorello E, Bigi A, Ansaloni R. The oral allergy syndrome. Ann Allergy 1988;61(6 Pt 2):47–52.
      1. Webber CM, England RW. Oral allergy syndrome: a clinical, diagnostic, and therapeutic challenge. Ann Allergy Asthma Immunol 2010;104(2):101–108.
      1. Ma S, Sicherer SH, Nowak-Wegrzyn A. A survey on the management of pollen-food allergy syndrome in allergy practices. J Allergy Clin Immunol 2003;112(4):784–788.
      1. Skypala IJ, Bull SC, Deegan K, Gruffydd-Jones K, Holmes S, Small I, et al. Prevalence of pollen-related oral allergy syndrome (OAS) in a UK population. J Allergy Clin Immunol 2010;125(2):AB218
      1. Canadian society of allergy and clinical immunology annual scientific meeting 2011 quebec, Canada. 20–23 October 2011. Abstracts. Allergy Asthma Clin Immunol 2011;7 Suppl 2:A1–A41.
      1. Dondi A, Tripodi S, Panetta V, Asero R, Businco AD, Bianchi A, et al. Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity. Pediatr Allergy Immunol 2013;24(8):742–751.
      1. Brown CE, Katelaris CH. The prevalence of the oral allergy syndrome and pollen-food syndrome in an atopic paediatric population in south-west Sydney. J Paediatr Child Health 2014;50(10):795–800.
      1. Ivičević N, Roje Ž, Kljajić Z, Bojić L, Kardum G, Omero L, et al. Prevalence and risk factors for developing oral allergy syndrome in adult patients with seasonal allergic rhinitis. Acta Clin Croat 2015;54(1):25–29.
      1. Ivković-Jureković I. Oral allergy syndrome in children. Int Dent J 2015;65(3):164–168.
      1. Bedolla-Barajas M, Kestler-Gramajo A, Alcalá-Padilla G, Morales-Romero J. Prevalence of oral allergy syndrome in children with allergic diseases. Allergol Immunopathol (Madr) 2017;45(2):127–133.
      1. Katelaris CH. Food allergy and oral allergy or pollen-food syndrome. Curr Opin Allergy Clin Immunol 2010;10(3):246–251.
      1. Cho YS, Lim YJ, Lee JC, Kim SH, Lim MK, Yoo B, et al. Oral allergy syndrome in pollen - sensitized patients. J Asthma Allergy Clin Immunol 1998;18(3):458–465.
      1. Maeda N, Inomata N, Morita A, Kirino M, Ikezawa Z. Correlation of oral allergy syndrome due to plant-derived foods with pollen sensitization in Japan. Ann Allergy Asthma Immunol 2010;104(3):205–210.
      1. Song DJ, Song WJ, Kwon JW, Kim GW, Kim MA, Kim MY, et al. KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res 2018;10(6):591–613.
      1. Geroldinger-Simic M, Zelniker T, Aberer W, Ebner C, Egger C, Greiderer A, et al. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J Allergy Clin Immunol 2011;127(3):616–622.e1.
      1. Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001;108(6):881–890.
      1. Vieths S. Allergenic cross-reactivity, food allergy and pollen. Environ Toxicol Pharmacol 1997;4(1-2):61–70.
      1. Amlot PL, Kemeny DM, Zachary C, Parkes P, Lessof MH. Oral allergy syndrome (OAS): symptoms of IgE-mediated hypersensitivity to foods. Clin Allergy 1987;17(1):33–42.
      1. Kondo Y, Urisu A. Oral allergy syndrome. Allergol Int 2009;58(4):485–491.
      1. Eriksson NE, Formgren H, Svenonius E. Food hypersensitivity in patients with pollen allergy. Allergy 1982;37(6):437–443.
      1. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998;101(3):E8
      1. Mailhol C, Giordano-Labadie F, Lauwers-Cances V, Ammoury A, Paul C, Rance F. Point prevalence and risk factors for food allergy in a cohort of 386 children with atopic dermatitis attending a multidisciplinary dermatology/paediatric allergy clinic. Eur J Dermatol 2014;24(1):63–69.
      1. Breuer K, Wulf A, Constien A, Tetau D, Kapp A, Werfel T. Birch pollen-related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome. Allergy 2004;59(9):988–994.
      1. Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 2011;41(3):298–310.
      1. Sampson HA. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1983;71(5):473–480.
      1. Kashyap RR, Kashyap RS. Oral allergy syndrome: an update for stomatologists. J Allergy (Cairo) 2015;2015:543928
      1. Bircher AJ, Van Melle G, Haller E, Curty B, Frei PC. IgE to food allergens are highly prevalent in patients allergic to pollens, with and without symptoms of food allergy. Clin Exp Allergy 1994;24(4):367–374.
    Cited by
    Crossref 18
    Google Scholar 
    PubMed Central 5
    Scopus 11
    Web of Science 11
    MeSH Terms
    Actinidia/immunology
    Adolescent
    Ambrosia/immunology
    Area Under Curve
    Betula/immunology*
    Child
    Child, Preschool
    Dermatitis, Atopic/complications
    Dermatitis, Atopic/diagnosis*
    Female
    Food Hypersensitivity/complications
    Food Hypersensitivity/diagnosis*
    Food Hypersensitivity/epidemiology
    Food Hypersensitivity/prevention & control
    Humans
    Immunoglobulin E/blood
    Immunoglobulin E/metabolism
    Male
    Malus/immunology
    Pollen/immunology
    Prevalence
    ROC Curve
    Republic of Korea/epidemiology
    Metrics
    Share
    Links to
    Figures
    slide

    1 / 1

    Tables
    slide
    slide
    slide
    slide

    1 / 4

    ORCID IDs
    Funding Information
    PERMALINK